Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/03/2002WO2002076211A1 Nicotine-containing oral dosage form
10/03/2002WO2002076210A1 Inhibition of human immunodeficiency virus reverse transcriptase
10/03/2002WO2002065834A3 Novel formulations of carvedilol
10/03/2002WO2002062794A3 Compounds
10/03/2002WO2002062784A8 Piperidinee derivatives as neurokinin 1 antagonists
10/03/2002WO2002062766A3 Melanocortin-4 receptor binding compounds and methods of use thereof
10/03/2002WO2002062293A3 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
10/03/2002WO2002060276A9 Combination of probiotics
10/03/2002WO2002059127A3 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002WO2002055533A3 Methods of using imxp-888 and imxp-888 antagonists
10/03/2002WO2002055489A3 Pim kinase-related methods
10/03/2002WO2002055027A3 Placebo effect and relaxation response
10/03/2002WO2002053125A3 Skin care product containing a retinoid and a retinoid booster system in a dual compartment package
10/03/2002WO2002045590A9 Method for regional administeration of preparations for curing liver tumors
10/03/2002WO2002040070A3 Method for restoring a damaged or degenerated intervertebral disc
10/03/2002WO2002034933A3 Methods and compositions for modifying biologically active target molecules
10/03/2002WO2002030942A3 Anhydro sugar derivatives of indolocarbazoles
10/03/2002WO2002030941A3 Topoisomerase inhibitors
10/03/2002WO2002029086A3 Nucleic acid sequences differentially expressed in cancer tissue
10/03/2002WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002WO2002022677A3 Variants of allergenic proteins of the group 2 of dermatophagoides
10/03/2002WO2002018407A3 Antisense oligonucleotides against vanilloid receptor 1
10/03/2002WO2002017921A3 Paroxetine compositions and processes for making the same
10/03/2002WO2002012188A3 Indole compounds useful for the treatment of cancer
10/03/2002WO2001096388A3 Compositions and methods for the therapy and diagnosis of colon cancer
10/03/2002WO2001089543A3 Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
10/03/2002WO2001087306A8 Compositions and methods for the treatment of colorectal cancer
10/03/2002WO2001085983A3 Methods for testing compounds useful for treating diabetic complications
10/03/2002WO2001076603A1 Medicinal compositions containing camptothecin derivative and ph regulating agent
10/03/2002WO2001073077A3 Regulation of human serine racemase enzyme
10/03/2002WO2001064187A8 Anaesthetic formulations
10/03/2002WO2001029020A9 Neuraminidase inhibitors
10/03/2002WO2001023385A9 Novel tropane analogs
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002WO2001019359A3 Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
10/03/2002WO2001017508A9 Cationic liposome delivery of taxanes to angiogenic blood vessels
10/03/2002WO1999053907A3 Composition for treating psoriasis containing evening primrose oil and vitamins e and b
10/03/2002WO1998036745A3 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis
10/03/2002US20020143331 Inter-spinous process implant and method with deformable spacer
10/03/2002US20020143211 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochlorid, processes for preparing thereof
10/03/2002US20020143196 Histone deacetylase inhibitors
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143188 Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
10/03/2002US20020143187 Nitric oxide donors and pharmaceutical compositions containing them
10/03/2002US20020143185 Nitrosation process
10/03/2002US20020143182 For therapy of diseases having uncontrolled cellular proliferation
10/03/2002US20020143179 For therapy of disorder of the central nervous system which responds to dopamine D3 ligands such as schizophrenia, depression, neuroses and psychoses
10/03/2002US20020143178 Pentacyclic taxan compound
10/03/2002US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143069 For therapy of polymorphoneutrophil (PMN) inflammation
10/03/2002US20020143068 As antineoplastic agents
10/03/2002US20020143067 Novel uses of dl-THP
10/03/2002US20020143066 Perylenequinones for use as photosensitizers and sonosensitizers
10/03/2002US20020143065 Useful for the delivery of the (+) tramadol enantiomer and the (-) tramadol enantiomer
10/03/2002US20020143064 Inhibiting vascularization of a tumor mass by administering chalcone compound
10/03/2002US20020143060 Preventing active oxygen injury by of citrulline to decrease active oxygen content
10/03/2002US20020143059 For conditioning skin
10/03/2002US20020143058 Blending ingredients including a hygroscopic salt of valproic acid, carbomer, and non-hygroscopic additive to form non-hygroscopic stable oral pharmaceutical formulation
10/03/2002US20020143057 Using diacerein or a pharmaceutically acceptable derivative or rhein for the manufacture of a pharmaceutical formulation for the treatment of psoriasis and diseases associated therewith
10/03/2002US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness
10/03/2002US20020143054 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
10/03/2002US20020143053 Carbamate compounds for use in preventing or treating anxiety disorders
10/03/2002US20020143052 Histone deacetylase inhibitors
10/03/2002US20020143051 Shelf-life
10/03/2002US20020143050 Premixed amiodarone parenteral solution and method for making the same
10/03/2002US20020143049 Compositions and methods for the prevention and treatment of cerebral ischemia
10/03/2002US20020143048 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
10/03/2002US20020143047 Methods for treating indomethacin responsive headaches
10/03/2002US20020143046 Used as calcium channel blockers
10/03/2002US20020143045 Reacting 4-(oxiran-2-ylmethoxy)-9H- carbazole with 2-(2-methoxyphenoxy)ethylamine to produce carvedilol
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143042 Method and composition for treating cancer using cellular organelle crystallizing agents
10/03/2002US20020143040 Having antipyretic action, analgesic action, anti-inflammatory action;side effect reduction
10/03/2002US20020143039 Methods and compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus
10/03/2002US20020143038 Parenteral formulation for epothilone analogs
10/03/2002US20020143037 For therapy of cancer, hematological disorders, e.g., hemoglobinopathies, and genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy.
10/03/2002US20020143036 Pentafluorobenzenesulfonamides and analogs
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143031 Providing subject suffering from a symptoms of cardiovascular disease and a purified enantiomer preparation of flosequinan; administering preparation to subject under conditions such that symptom is reduced
10/03/2002US20020143030 Treatment of gastroparesis in certain patient groups
10/03/2002US20020143029 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/03/2002US20020143028 For therapy of pain
10/03/2002US20020143027 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143022 Inhibiting growth of neoplastic cells comprising exposings the cells to a growth inhibiting effective amount of indole derivative
10/03/2002US20020143021 Administering to vertebrate an effective tumor-growth-inhibiting phenylahistin compound or prodrug ester for therapy of cancer
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143019 2-aminoalkylaminoquinolines as dopamine D4 ligands
10/03/2002US20020143018 For therapy of animals infected with parasites that cause abortigenic or neurologic diseases, for therapy of parasitic protozoa such as coccidia that cause abortigenic or neurologic diseases of mammals
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020143016 Administering to a patient suffering from anxiety a therapeutically or prophylactically effective amount of N-desmethylzopiclone, or a pharmaceutically acceptable salt, solvate, hydrate, or clathrate
10/03/2002US20020143015 Use of vardenafil or pharmaceutically or veterinarily acceptable salt, or solvate in preparation of a medicament for curative, palliative or prophylactic therapy of type 2 diabetes mellitus
10/03/2002US20020143014 Aryl and heteroaryl substituted tetrahydroisoquinolines and use thereof
10/03/2002US20020143012 For imaging amyloid deposits
10/03/2002US20020143011 Tri-substituted phenyl derivatives and processes for their preparation
10/03/2002US20020143010 Compounds for treating fibromyalgia and chronic fatigue syndrome
10/03/2002US20020143009 Novel bicyclic oxazolidinones as antibacterial agents
1 ... 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 5704 5705 5706 5707 5708 5709 5710 ... 7860